{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "805bab46-97c6-45f1-948b-eebc1eb09b52", "code": "33643-45-7", "type": "SUPERSEDED", "url": "https://commonchemistry.cas.org/detail?cas_rn=33643-45-7", "code_system": "CAS", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c", "4da005ca-ec85-4d67-bfe0-8dc4164ad445" ] }, { "uuid": "bd210d76-d7e4-4946-a11a-80b475844aae", "code": "79499-51-7", "type": "SUPERSEDED", "url": "https://commonchemistry.cas.org/detail?cas_rn=79499-51-7", "code_system": "CAS", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c", "1060b723-563e-4ff3-973d-f3634efc9a81" ] }, { "uuid": "872113e4-84e1-40fe-985f-b5105d7eb1a5", "code": "100477-72-3", "type": "SUPERSEDED", "url": "https://commonchemistry.cas.org/detail?cas_rn=100477-72-3", "code_system": "CAS", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c", "a06e1cd6-147a-4eba-ad03-6b79ee26fb9d" ] }, { "uuid": "6a9d850d-593a-4d01-87a4-339876a1a1c1", "code": "CHEMBL742", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL742", "code_system": "ChEMBL", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "3c6a4bb9-1e51-4ac8-89a2-f6d606006b67", "code": "3821", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3821", "code_system": "PUBCHEM", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "e8990573-8581-434d-9b41-e12ee73e0393", "code": "N01AX03", "comments": "ATC|NERVOUS SYSTEM|ANESTHETICS|ANESTHETICS, GENERAL|Other general anesthetics|ketamine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N01AX03&showdescription=yes", "code_system": "WHO-ATC", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "1c53da54-a6c0-4e63-b599-08039f8acd3f", "code": "N0000175681", "comments": "Established Pharmacologic Class [EPC]|General Anesthetic [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175681", "code_system": "NDF-RT", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "e7f9d03d-d4a2-434c-b0a3-74e74be5712f", "code": "N0000175975", "comments": "Physiological Effects [PE]|Organ System Specific Effects [PE]|Nervous System Activity Alteration [PE]|Central Nervous System Activity Alteration [PE]|Central Nervous System Depression [PE]|General Anesthesia [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175975", "code_system": "NDF-RT", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "97093c27-bdb7-49d6-9757-c011dc557de4", "code": "QN01AX03", "comments": "VATC|ANESTHETICS|ANESTHETICS, GENERAL|Other general anesthetics|ketamine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN01AX03&showdescription=yes", "code_system": "WHO-VATC", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "6a88d8f5-08e5-4af6-8223-c2cc2a26dd03", "code": "6740-88-1", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=6740-88-1", "code_system": "CAS", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c", "31ff13e0-6e70-4b05-ab6d-5e0c15f2a8e6" ] }, { "uuid": "bd840582-c07e-4554-8654-efda961434e3", "code": "C61797", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61797", "code_system": "NCI_THESAURUS", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "cb511657-71c2-4558-a256-dd618e689b87", "code": "D007649", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68007649", "code_system": "MESH", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "e8a1169f-c1e7-4cb0-aed1-b67a2d268dbc", "code": "NBK548337", "comments": "LiverTox|CNS|Anesthetic|NMDA receptor antagonist", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548337/", "code_system": "LIVERTOX", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "a36fa5e0-b274-4ba2-9c24-81cf867719aa", "code": "1.1.2", "comments": "WHO ESSENTIAL MEDICINES LIST|Anaesthetics|General anaesthetics and oxygen|Injectable medicines", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/6/?section=30#type8", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "fdf67b73-1636-46e7-a4ba-6dfff1f6a3d0", "code": "KETAMINE", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Ketamine", "code_system": "WIKIPEDIA", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "05ccf4cb-f132-414d-bd1c-f0f7ac584eab", "code": "21 CFR 522.1222A", "comments": "PART 522 IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS|Sec. 522.1222a Ketamine.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=522.1222a", "code_system": "CFR", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "4602bdbd-3cee-46dc-9499-17cc98d5b81a", "code": "SUB08365MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "278476f5-1862-44c3-84f8-c186ca484c7d", "code": "2156", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=2156", "code_system": "INN", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "d38cc047-da3d-4a01-bb97-71c7bf87f092", "code": "7285", "comments": "PART 1308 -- SCHEDULES OF CONTROLLED SUBSTANCES|Sec. 1308.11 Schedule III.|Depressants", "type": "PRIMARY", "url": "http://www.ecfr.gov/cgi-bin/text-idx?rgn=div5&node=21:9.0.1.1.9#se21.9.1308_111", "code_system": "DEA NO.", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "6b7d0563-3d5d-4e97-84fa-d12a2d362b2c", "code": "229-804-1", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.027.095", "code_system": "ECHA (EC/EINECS)", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "87421d50-5505-4d74-9fb5-c76ed40b8514", "code": "4233", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4233", "code_system": "IUPHAR", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "8e2f5e68-5559-40c1-9a7a-811ad34ed803", "code": "6130", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/6130/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "f148cef0-318e-4cf3-8564-dae50efe41c7", "code": "m6613", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m6613?q=authorize", "code_system": "MERCK INDEX", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "30204e5e-31df-41df-8049-0d95dbb017a7", "code": "DB01221", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB01221", "code_system": "DRUG BANK", "references": [ "be44e70a-850c-4146-8a2e-919bedede16c" ] }, { "uuid": "081f49cb-5d44-54a9-412c-b41784238d7b", "code": "2180", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/2180", "code_system": "HSDB", "references": [ "f740e5d9-8135-a7d2-b8bc-47dca3c7206a" ] }, { "uuid": "ed3a88a6-e9c8-2dc2-851d-ab9c114e4751", "code": "DTXSID8023187", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID8023187", "code_system": "EPA CompTox", "references": [ "51716d59-2e66-231e-2536-3f26fdaf03b0" ] }, { "uuid": "8e87d430-51f7-67f4-1e9c-1c20a84f65fb", "code": "288809", "comments": "ORPHAN DRUG|Designated|Treatment of postherpetic neuralgia", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=288809", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "014fd52a-13d2-9cdb-8426-17ffa8324bae", "code": "C245", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Anesthetic Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C245", "code_system": "NCI_THESAURUS", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "4130b03a-ff40-8335-4d16-52e4b47113b3", "code": "669318", "comments": "ORPHAN DRUG|Designated|Treatment of Complex Regional Pain Syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=669318", "code_system": "FDA ORPHAN DRUG", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "a0a600aa-6a97-4b0d-a331-a9f855ae5051", "code": "690G0D6V8H", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "e2b72d92-ff76-9653-0d88-f85052f908ef", "code": "Ketamine", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM1004/", "code_system": "LACTMED", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "52b9e3e4-500d-0e5c-cc55-04ebd13fa640", "code": "1523", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/1523", "code_system": "DRUG CENTRAL", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "31b44bc0-cfa2-bd44-b0d4-38d34ddbdfd5", "code": "829921", "comments": "ORPHAN DRUG|Designated|Treatment of Amyotrophic Lateral Sclerosis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=829921", "code_system": "FDA ORPHAN DRUG", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "95582472-0e33-15b2-c750-4084ab421850", "code": "6121", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:6121", "code_system": "CHEBI", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "f4b0a1a3-341f-2cbe-210c-e87dae98cef0", "code": "840821", "comments": "ORPHAN DRUG|Designated|Treatment of Complex Regional Pain Syndrome (CRPS)", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=840821", "code_system": "FDA ORPHAN DRUG", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "8b45a4a9-f169-114c-d8c9-9287448b8440", "code": "812221", "comments": "ORPHAN DRUG|Designated|Treatment of Complex Regional Pain Syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=812221", "code_system": "FDA ORPHAN DRUG", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "5ab13a75-6233-0c82-0a54-90c80ccd5be6", "code": "70151", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=70151", "code_system": "NSC", "references": [ "026b38c7-ce9e-ae1a-735a-85f0cd50ef12" ] }, { "uuid": "a827d894-1279-d39d-337d-9b48cc4f0765", "code": "883122", "comments": "ORPHAN DRUG|Designated|Treatment of Complex Regional Pain Syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=883122", "code_system": "FDA ORPHAN DRUG", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] }, { "uuid": "40901f7f-5873-7b78-1f87-0998184534a1", "code": "100000082867", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "a2a4805f-109a-75f1-fb5c-3473283ee821" ] }, { "uuid": "8da7e365-f870-3386-5214-7db96a0b657a", "code": "690G0D6V8H", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=690G0D6V8H", "code_system": "DAILYMED", "references": [ "93b91832-5fdc-20df-ff49-f7f259442c93" ] }, { "uuid": "e6c06056-7420-f4cb-ef0b-7f236a59b936", "code": "922622", "comments": "ORPHAN DRUG|Designated|Treatment of Rett Syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=922622", "code_system": "FDA ORPHAN DRUG", "references": [ "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe" ] } ], "substance_class": "chemical", "references": [ { "uuid": "91189ca3-3921-4258-a1cc-b9963c9bcc17", "citation": "USP Dictionary 2009", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "1fabe8c4-a10b-4c70-8710-47606f2714ea", "citation": "USP DICTIONARY 2009", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9d9720ef-757b-43d6-bfc0-c7d35058d0b7", "citation": "INN Proposed List 16", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL16.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "dc405450-342b-4693-8157-b1ee6bcabf86", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "60e1acd9-9fe5-4526-a536-4754ee99bf23", "citation": "KEGG 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9295c11a-7af9-4c5f-b973-e440f63e7484", "citation": "D08098", "doc_type": "KEGG", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "51d3e0d3-c5c2-4b45-ac86-dad85c12d2f4", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "317ec9cb-8091-4051-b630-b1f645901888", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "eb7f110d-62b9-4b8a-ba2e-b65e8c24a471", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "1d9c11e2-a83a-445f-98e1-246a46549a49", "citation": "STN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "be44e70a-850c-4146-8a2e-919bedede16c", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493390735000, "tags": [ "NOMEN" ] }, { "uuid": "d2ac64d6-871a-40e1-aceb-c5ee5130200f", "citation": "SRS import [690G0D6V8H]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=690G0D6V8H", "doc_type": "SRS", "public_domain": true, "document_date": 1493390735000, "tags": [ "NOMEN" ] }, { "uuid": "447bbf0b-f321-4e28-9261-883e9c22e5f2", "citation": "KETAMINE [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "c480c254-c9cd-4eb1-86a4-584b87951b13", "citation": "KETAMINE [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "08abec44-d9c4-4add-8f7b-2d7afde5fe35", "citation": "KETAMINE [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "7546cc50-f5f5-493b-a70e-d4c1e727366f", "citation": "KETAMINE [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "745824fe-bd2d-40ff-ab55-843cf69f2c23", "citation": "KETAMINE [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "4e0dcfee-7dbc-4107-beaf-3382200ca357", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "ca46baac-6b83-a836-8bb4-988697ca6068", "citation": "West J Emerg Med. 2008 Jan; 9(1): 20–23.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672224/", "doc_type": "JA", "public_domain": true }, { "uuid": "2f08e74e-ab52-557a-1fd4-197d413b2efc", "citation": "https://en.wikipedia.org/wiki/Dopamine_receptor_D2", "url": "https://en.wikipedia.org/wiki/Ketamine", "doc_type": "JA", "public_domain": true }, { "uuid": "0031434e-0e6f-b2b2-6f3e-5cc1bf203e4b", "citation": "Pharmacol Rev 65:578–640, April 2013", "url": "http://dx.doi.org/10.1124/pr.111.005439", "doc_type": "JA", "public_domain": true }, { "uuid": "f740e5d9-8135-a7d2-b8bc-47dca3c7206a", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+6740-88-1", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "51716d59-2e66-231e-2536-3f26fdaf03b0", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=6740-88-1", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "cf52acbd-f95a-013e-7aff-f7a4eff77dbd", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+6740-88-1", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8256f6f5-a229-ee40-f44c-3c0c8ce03cd0", "citation": "https://www.clinicalkey.com/pharmacology/monograph/333?sec=monphar", "doc_type": "LEPINDEX", "public_domain": true }, { "uuid": "a2a4805f-109a-75f1-fb5c-3473283ee821", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "71dc67a6-3cc9-7f23-ce6c-2c446fbc99fe", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "31ff13e0-6e70-4b05-ab6d-5e0c15f2a8e6", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "a06e1cd6-147a-4eba-ad03-6b79ee26fb9d", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "1060b723-563e-4ff3-973d-f3634efc9a81", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "4da005ca-ec85-4d67-bfe0-8dc4164ad445", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "fd0d443c-6bf7-7bfe-fd90-79dc27488e67", "citation": "https://clinicaltrials.gov/ct2/show/NCT00492388", "url": "https://clinicaltrials.gov/ct2/show/NCT00492388", "doc_type": "CLINICAL_TRIALS.GOV", "public_domain": true }, { "uuid": "3adb853e-72b9-4eac-91fb-c948eb4209c4", "citation": "Pharmacol Rev 65:578–640, April 2013", "url": "http://dx.doi.org/10.1124/pr.111.005439", "doc_type": "JA", "public_domain": true }, { "uuid": "6c376e16-6a17-426c-a60b-7e2341ca2ebc", "citation": "Biomed Mass Spectrom 1981;8(11):527", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "82beb962-173c-4500-8e78-16d980fe167c", "citation": "Pharmacol Rev 65:578–640, April 2013", "url": "http://dx.doi.org/10.1124/pr.111.005439", "doc_type": "JA", "public_domain": true }, { "uuid": "98b8148b-056d-4476-b97b-c4feae9e8054", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "9a81c399-102e-473a-bc24-f484d6cef375", "citation": "Hess, Evan M., et al. \"Mechanisms of Ketamine and its Metabolites as Antidepressants.\" Biochemical Pharmacology (2021): 114892.", "url": "https://www.sciencedirect.com/science/article/pii/S0006295221005189", "doc_type": "JA", "public_domain": true }, { "uuid": "026b38c7-ce9e-ae1a-735a-85f0cd50ef12", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "14737fa4-122b-2065-80d6-46b233f2e667", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "93b91832-5fdc-20df-ff49-f7f259442c93", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "410fbb29-61a5-4cf3-b72a-20f1532a3580", "citation": "https://en.wikipedia.org/wiki/Ketamine", "url": "https://en.wikipedia.org/wiki/Ketamine", "doc_type": "WIKI", "public_domain": true }, { "uuid": "04a6209a-3030-4a2d-ac1a-780d04484150", "citation": "https://www.drugsdata.org/stats_substance_by_year.php", "url": "https://www.drugsdata.org/stats_substance_by_year.php", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "adedf850-4b79-41e2-a97b-35348bbe421c", "citation": "https://www.caymanchem.com/product/22213/ketamine-hydroxylimine-precursor-(hydrochloride)", "url": "https://www.caymanchem.com/product/22213/ketamine-hydroxylimine-precursor-(hydrochloride)", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "8409cb4d-a8b6-4096-a424-60b1a7d20a32", "citation": "https://www.caymanchem.com/product/22213/ketamine-hydroxylimine-precursor-(hydrochloride)", "url": "https://www.caymanchem.com/product/22213/ketamine-hydroxylimine-precursor-(hydrochloride)", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "85987558-d5d8-4c82-a9a6-2bf969809c30", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "d1c93444-4fea-4c8b-9e7e-b778cb632e7f", "citation": "https://www.caymanchem.com/product/22213/ketamine-hydroxylimine-precursor-(hydrochloride)", "url": "https://www.caymanchem.com/product/22213/ketamine-hydroxylimine-precursor-(hydrochloride)", "doc_type": "WEB PAGE", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "e411b3c6-e81f-45d8-a6a7-76f9507c4c74", "id": "e411b3c6-e81f-45d8-a6a7-76f9507c4c74", "molfile": "\n Marvin 02242316322D \n\n 16 17 0 0 1 0 999 V2000\n 4.6294 -0.6758 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6500 -0.1115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.6664 0.6029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 3.0789 -0.1115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7934 -0.5240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7934 -1.3490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.0789 -1.7615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.3644 -0.5240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.3644 -1.3490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.7109 0.4188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.4862 0.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.5676 1.2312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.8414 0.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.1181 0.6669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.1997 1.7615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.9749 1.4794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1 11 1 0 0 0 0\n 2 8 2 0 0 0 0\n 3 4 1 0 0 0 0\n 3 13 1 0 0 0 0\n 4 5 1 0 0 0 0\n 4 8 1 0 0 0 0\n 4 10 1 0 0 0 0\n 5 6 1 0 0 0 0\n 6 7 1 0 0 0 0\n 7 9 1 0 0 0 0\n 8 9 1 0 0 0 0\n 10 11 1 0 0 0 0\n 10 12 2 0 0 0 0\n 11 14 2 0 0 0 0\n 12 15 1 0 0 0 0\n 14 16 1 0 0 0 0\n 15 16 2 0 0 0 0\nM END", "smiles": "CNC1(CCCCC1=O)c2ccccc2Cl", "formula": "C13H16ClNO", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "RACEMIC", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "540266f1-c50e-46a7-b8dd-326fb3f51d57" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "237.7257", "optical_activity": "( + / - )", "stereo_centers": 1 } ], "definition_level": "COMPLETE", "uuid": "7cc1ec1a-533a-4255-9add-49e0ec44b680", "version": "61", "structure": { "id": "87f454e7-866e-4b5d-8b39-54772e549aa6", "molfile": "3821\n JSDraw202242316322D\n\n 16 17 0 0 0 0 0 V2000\n 26.8988 -8.9739 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0\n 21.2651 -7.9068 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 23.1870 -6.5560 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 23.9670 -7.9068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.3180 -8.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.3180 -10.2468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 23.9670 -11.0268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.6160 -8.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 22.6160 -10.2468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.1620 -6.9041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 26.6280 -7.4377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 24.8911 -5.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 21.6270 -6.5560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.8229 -6.4350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 26.0863 -4.3652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.5521 -4.8986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1 11 1 0 0 0 0\n 2 8 2 0 0 0 0\n 3 4 1 0 0 0 0\n 3 13 1 0 0 0 0\n 4 5 1 0 0 0 0\n 4 8 1 0 0 0 0\n 4 10 1 0 0 0 0\n 5 6 1 0 0 0 0\n 6 7 1 0 0 0 0\n 7 9 1 0 0 0 0\n 8 9 1 0 0 0 0\n 10 11 1 0 0 0 0\n 10 12 2 0 0 0 0\n 11 14 2 0 0 0 0\n 12 15 1 0 0 0 0\n 14 16 1 0 0 0 0\n 15 16 2 0 0 0 0\nM END", "smiles": "CNC1(CCCCC1=O)c2ccccc2Cl", "formula": "C13H16ClNO", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "RACEMIC", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "237.7257", "optical_activity": "( + / - )", "references": [ "d2ac64d6-871a-40e1-aceb-c5ee5130200f", "91189ca3-3921-4258-a1cc-b9963c9bcc17", "9d9720ef-757b-43d6-bfc0-c7d35058d0b7" ], "stereo_centers": 1 }, "unii": "690G0D6V8H", "relationships": [ { "uuid": "c798cc50-bf15-4ca6-b634-4c1867ae7246", "amount": { "uuid": "c5008f50-e2e1-4fde-9ead-f7eb9fc268f5" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "d70216df-99a4-49f9-99bf-ac7d4ff92600", "refuuid": "7cc1ec1a-533a-4255-9add-49e0ec44b680", "name": "KETAMINE", "unii": "690G0D6V8H", "linking_id": "690G0D6V8H", "ref_pname": "KETAMINE", "substance_class": "reference" } }, { "uuid": "d80ac2cc-4408-44d2-aac2-6202f9fcb7d7", "amount": { "uuid": "4611c33a-8ad1-4d7d-b720-e89f217bc0fb" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "6a046053-bf70-4598-a8c6-307fe5ab940d", "refuuid": "13959e26-41fb-4b9f-8275-1c821d2df825", "name": "KETAMINE HYDROCHLORIDE", "unii": "O18YUO0I83", "linking_id": "O18YUO0I83", "ref_pname": "KETAMINE HYDROCHLORIDE", "substance_class": "reference" } }, { "uuid": "61a78ed7-e8c1-451e-93f1-9fb8101b74cd", "amount": { "uuid": "7ad2589e-5a14-47e4-a007-b885d65e28e9" }, "type": "METABOLITE ACTIVE->PARENT", "references": [ "3adb853e-72b9-4eac-91fb-c948eb4209c4", "6c376e16-6a17-426c-a60b-7e2341ca2ebc" ], "related_substance": { "uuid": "20aa4c9a-2237-4aba-9696-9e179454cc90", "refuuid": "aea54954-2eec-4ee4-b3eb-3f6ca7eae06b", "name": "NORKETAMINE", "unii": "XQY6JVF94X", "linking_id": "XQY6JVF94X", "ref_pname": "NORKETAMINE", "substance_class": "reference" } }, { "uuid": "0602c982-34cd-4069-b8d2-edeccdf39972", "amount": { "uuid": "4170a2a7-4dc5-4282-8a3a-7b3d15c43713" }, "type": "ENANTIOMER->RACEMATE", "related_substance": { "uuid": "e1bd962f-2903-495a-aea2-6fb0133d5096", "refuuid": "28b8d30e-5344-425c-a0a6-ffa69bff3dbf", "name": "Ketamine, (R)-", "unii": "Y2RI13H7VW", "linking_id": "Y2RI13H7VW", "ref_pname": "Ketamine, (R)-", "substance_class": "reference" } }, { "uuid": "bc1babfe-7039-4e92-9ef3-9ee5f2fd5036", "amount": { "uuid": "745e55cf-263e-462a-be98-cb3ba1d78a81" }, "type": "ENANTIOMER->RACEMATE", "related_substance": { "uuid": "a4660a02-28e4-41df-a245-a02ad252a401", "refuuid": "265d1945-c394-4941-bb94-c43ed9ceee85", "name": "Esketamine", "unii": "50LFG02TXD", "linking_id": "50LFG02TXD", "ref_pname": "Esketamine", "substance_class": "reference" } }, { "uuid": "9156a835-beb4-43a8-9aca-85106c08585a", "amount": { "uuid": "80f23cd4-770b-41c2-9fd3-b76f095c59d4", "average": 60, "units": "%" }, "type": "BINDER->LIGAND", "references": [ "0031434e-0e6f-b2b2-6f3e-5cc1bf203e4b" ], "related_substance": { "uuid": "9f9315a0-6755-4712-b2e9-fc90bf18a6f5", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "68d983a4-3ed6-4181-97dd-2b815f238f65", "amount": { "uuid": "c4808bef-00f3-4f6c-8a07-898b92726d0a" }, "type": "METABOLITE ACTIVE->PARENT", "related_substance": { "uuid": "9af54acd-0882-4564-9f90-31cd8a1e7f9c", "refuuid": "67baa08e-ded6-4a19-95c4-d805d05b07ea", "name": "DEHYDRONORKETAMINE", "unii": "J5442FVV58", "linking_id": "J5442FVV58", "ref_pname": "DEHYDRONORKETAMINE" } }, { "uuid": "2cbd0eef-853a-4f34-9341-331fea486bd2", "amount": { "uuid": "98e97c5e-6933-4a67-a973-737d74f0a5be" }, "type": "METABOLITE LESS ACTIVE->PARENT", "related_substance": { "uuid": "3853ed4c-b573-4dd5-9eb1-700387b73f58", "refuuid": "45492678-c453-478d-bb4c-cbe49c522014", "name": "DEHYDRONORKETAMINE, (R)-", "unii": "S237YWP5TL", "linking_id": "S237YWP5TL", "ref_pname": "DEHYDRONORKETAMINE, (R)-" } }, { "uuid": "5f8e1b45-13d9-4b32-94e4-b02757014f8a", "amount": { "uuid": "75f19ddb-4958-4e11-945a-2241fe1e539d" }, "type": "METABOLITE ACTIVE->PARENT", "references": [ "9a81c399-102e-473a-bc24-f484d6cef375" ], "related_substance": { "uuid": "72cb410a-32ce-48f8-8151-7f70aaeff62d", "refuuid": "e5f1eaf8-9e3f-4ba2-86aa-9b5e6e0c8a19", "name": "Hydroxynorketamine (R,R;S,S)", "unii": "HB3B4A37KE", "linking_id": "HB3B4A37KE", "ref_pname": "Hydroxynorketamine (R,R;S,S)", "substance_class": "reference" } }, { "uuid": "ecf905ea-eea8-4662-bd87-624cef308f6f", "amount": { "uuid": "dcad877d-bf4b-42b2-a567-a405c67ca891" }, "type": "METABOLITE ACTIVE->PARENT", "related_substance": { "uuid": "4782ba29-36f4-4584-aefb-71e31fa4cf37", "refuuid": "570c5ec7-b6d6-42ec-8dfa-e3785c3647e8", "name": "DEHYDRONORKETAMINE, (S)-", "unii": "WNA26ZXF3F", "linking_id": "WNA26ZXF3F", "ref_pname": "DEHYDRONORKETAMINE, (S)-" } }, { "uuid": "0b6b3dc4-6fb2-4387-8d36-6340e5db71fa", "amount": { "uuid": "a6f19bdd-5af8-441a-a15b-9cf299dc3fb0" }, "comments": "MAJOR METABOLITE IN PLASMA", "type": "METABOLITE ACTIVE->PARENT", "related_substance": { "uuid": "678349ef-a0d5-4954-95cd-4ab799ddf182", "refuuid": "8b188ed5-1285-41df-a56e-88cb14e9723e", "name": "HYDROXYNORKETAMINE, (2S,6S)-", "unii": "V7MB1GM2IM", "linking_id": "V7MB1GM2IM", "ref_pname": "HYDROXYNORKETAMINE, (2S,6S)-" } }, { "uuid": "dda84d59-0c4f-4b2a-ab81-2176b9b8026b", "amount": { "uuid": "c194e667-7636-4670-ad88-3aad37af08ff" }, "comments": "MAJOR METABOLITE IN PLASMA MAY BE RESPONSIBLE ANTI-DEPRESSIVE ACTIVITY.", "type": "METABOLITE ACTIVE->PARENT", "related_substance": { "uuid": "c8b0e135-1939-45b7-84aa-4c2bfaf05b09", "refuuid": "210165ef-4c69-4154-918c-6f8dd93e05aa", "name": "HYDROXYNORKETAMINE, (2R,6R)-", "unii": "HB1X671CEU", "linking_id": "HB1X671CEU", "ref_pname": "HYDROXYNORKETAMINE, (2R,6R)-" } }, { "uuid": "4db262a3-5c90-4d1f-910c-4957544c7e07", "amount": { "uuid": "54fd78d3-e9da-4141-b959-60d01963296c" }, "comments": "MINOR", "type": "METABOLITE->PARENT", "references": [ "98b8148b-056d-4476-b97b-c4feae9e8054" ], "related_substance": { "uuid": "9d7c017b-ef95-4eea-8864-e0d9223af16c", "refuuid": "5355ba72-0d35-4c92-aa9f-9d6934560d32", "name": "HYDROXYNORKETAMINE", "unii": "6VAD9SC8NW", "linking_id": "6VAD9SC8NW", "ref_pname": "HYDROXYNORKETAMINE" } }, { "uuid": "e03c3af0-c63e-405f-a413-b1bd58175f3d", "amount": { "uuid": "3e5717a0-d27f-4088-8795-8b83ff323bca", "high": 660, "low": 250, "units": "NANOMOLAR" }, "comments": "Channel blocker", "qualification": "Ki", "type": "TARGET->INHIBITOR", "interaction_type": "UNCOMPETITIVE", "related_substance": { "uuid": "f74f6df1-07a0-47ef-b3ce-3d307f3b2f1e", "refuuid": "562fff79-34fb-400d-9fc2-ec5e206f85b6", "name": "NMDA RECEPTOR", "unii": "4R3XO922WS", "linking_id": "4R3XO922WS", "ref_pname": "NMDA RECEPTOR", "substance_class": "reference" } }, { "uuid": "75aa3531-7ec6-4542-94c1-9e2f179c8cff", "amount": { "uuid": "62b7a3a4-9cb6-4a6f-9a79-b046811616b5" }, "comments": "Intermediate", "type": "PRECURSOR->PARENT", "references": [ "d1c93444-4fea-4c8b-9e7e-b778cb632e7f" ], "related_substance": { "uuid": "f948669f-287a-43db-be67-f3180ffab8c9", "refuuid": "8c7aa903-a2e5-43f6-a717-f0e71177cff9", "name": "1-[(2-Chlorophenyl)(methylimino)methyl]cyclopentan-1-ol", "unii": "HGI99H315N", "linking_id": "HGI99H315N", "ref_pname": "1-[(2-Chlorophenyl)(methylimino)methyl]cyclopentan-1-ol", "substance_class": "reference" } } ], "names": [ { "uuid": "4e1f6422-016b-43ef-bc10-3749aa49bec6", "name": "(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE", "stdName": "(+/-)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1fabe8c4-a10b-4c70-8710-47606f2714ea" ], "display_name": false }, { "uuid": "5868921d-0bfb-4d0c-8924-6a4c5d3e72b2", "name": "(±)-KETAMINE", "stdName": "(+/-)-KETAMINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "6e56f158-70ac-42d9-99df-7c8bd17057ee", "name": "ANAKET V", "stdName": "ANAKET V", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "45614b3e-28d1-4c62-9b7d-141f034159ea", "name": "CALYPSOL", "stdName": "CALYPSOL", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "dc14780f-5cdc-45fd-b812-5a1fc62bc276", "name": "CLORKETAM 1000", "stdName": "CLORKETAM 1000", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "8dc48a9b-ce92-46b6-ab8b-27520584a917", "name": "CYCLOHEXANONE, 2-(2-CHLOROPHENYL)-2-(METHYLAMINO)-", "stdName": "CYCLOHEXANONE, 2-(2-CHLOROPHENYL)-2-(METHYLAMINO)-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "1fabe8c4-a10b-4c70-8710-47606f2714ea" ], "display_name": false }, { "uuid": "4a84c8f2-9488-4190-9296-5d07e3e696b3", "name": "CYCLOHEXANONE, 2-(2-CHLOROPHENYL)-2-(METHYLAMINO)-, (±)-", "stdName": "CYCLOHEXANONE, 2-(2-CHLOROPHENYL)-2-(METHYLAMINO)-, (+/-)-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "def82622-6256-4085-88cc-e41c14912818", "name": "DL-KETAMINE", "stdName": "DL-KETAMINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "63c90052-06c0-4181-9225-b869cfca6a08", "name": "IMALGENE 1000", "stdName": "IMALGENE 1000", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "2ed0acb2-681e-ed5e-e1fd-dc2f3d4aa051", "name": "KETAFOL COMPONENT KETAMINE", "stdName": "KETAFOL COMPONENT KETAMINE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "ca46baac-6b83-a836-8bb4-988697ca6068" ], "display_name": false }, { "uuid": "c0a4de61-8062-4e68-aa50-0f0e59c76a9e", "name": "KETAMINE", "stdName": "KETAMINE", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "51d3e0d3-c5c2-4b45-ac86-dad85c12d2f4", "dc405450-342b-4693-8157-b1ee6bcabf86", "745824fe-bd2d-40ff-ab55-843cf69f2c23", "317ec9cb-8091-4051-b630-b1f645901888", "c480c254-c9cd-4eb1-86a4-584b87951b13", "eb7f110d-62b9-4b8a-ba2e-b65e8c24a471", "9d9720ef-757b-43d6-bfc0-c7d35058d0b7", "447bbf0b-f321-4e28-9261-883e9c22e5f2", "91189ca3-3921-4258-a1cc-b9963c9bcc17", "08abec44-d9c4-4add-8f7b-2d7afde5fe35", "7546cc50-f5f5-493b-a70e-d4c1e727366f" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "958a10d6-3b5b-417b-96ad-3b7456728816", "name_org": "INN" } ] }, { "uuid": "f426b2e8-ab1f-4df0-95ab-55e28e264117", "name": "KETAMINE [HSDB]", "stdName": "KETAMINE [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "51d3e0d3-c5c2-4b45-ac86-dad85c12d2f4" ], "display_name": false }, { "uuid": "a90ff80f-8f7c-4fe4-bf88-865cc3cfb113", "name": "KETAMINE [MI]", "stdName": "KETAMINE [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "dc405450-342b-4693-8157-b1ee6bcabf86" ], "display_name": false }, { "uuid": "796ed730-e363-4222-bbce-94a4f6b51113", "name": "KETAMINE [VANDF]", "stdName": "KETAMINE [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "eb7f110d-62b9-4b8a-ba2e-b65e8c24a471" ], "display_name": false }, { "uuid": "65298fae-ab6c-4d59-9b4b-28538125e29a", "name": "KETASOL 100", "stdName": "KETASOL 100", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "c256c597-fd5b-7da2-8979-eda64768e686", "name": "Ketamine [WHO-DD]", "stdName": "KETAMINE [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "14737fa4-122b-2065-80d6-46b233f2e667" ], "display_name": false }, { "uuid": "8a2ca0eb-36fa-4986-a1a9-d1aec56dcb69", "name": "NARKETAN", "stdName": "NARKETAN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "15fa7d97-094c-41ef-87f1-d01fbbed3157", "name": "NSC-70151", "stdName": "NSC-70151", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "191fdf30-8502-dd83-de04-8bc9fe8f4523", "name": "PMI-150", "stdName": "PMI-150", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "fd0d443c-6bf7-7bfe-fd90-79dc27488e67" ], "display_name": false }, { "uuid": "685ebca0-a27a-439c-af2a-9af36a055b95", "name": "Special K", "stdName": "SPECIAL K", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "410fbb29-61a5-4cf3-b72a-20f1532a3580" ], "display_name": false }, { "uuid": "461d4f5a-b9a3-4ec5-a7d2-9e6b23164854", "name": "TEKAM", "stdName": "TEKAM", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "9295c11a-7af9-4c5f-b973-e440f63e7484", "60e1acd9-9fe5-4526-a536-4754ee99bf23" ], "display_name": false }, { "uuid": "ac411c1e-8612-468d-ad13-e0f99e0ac25f", "name": "URSOTAMIN", "stdName": "URSOTAMIN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "2fef4846-20e6-4b79-a8e7-c3bc1f631716", "name": "VETAKET", "stdName": "VETAKET", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "1d9c11e2-a83a-445f-98e1-246a46549a49" ], "display_name": false }, { "uuid": "e780c9c8-d2fe-4ffa-b0b6-fe6ce162ce91", "name": "ketamine [INN]", "stdName": "KETAMINE [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9d9720ef-757b-43d6-bfc0-c7d35058d0b7" ], "display_name": false } ], "properties": [ { "uuid": "47d462b5-5db0-4b56-9052-7ac383c6aca2", "name": "Biological Half-life", "value": { "uuid": "1a99be5b-4e68-4d2b-a351-93f3d6761cf1", "high": 3, "low": 2, "units": "hours" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "8256f6f5-a229-ee40-f44c-3c0c8ce03cd0" ] } ] } ] }